These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6530700)

  • 41. [Measures to reduce absorption in the treatment of intoxications].
    de Vries I; van Zoelen GA; van Riel AJ; Meulenbelt J
    Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2964-8. PubMed ID: 16425848
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thermodynamic evaluation of activated charcoal as a poison antidote by high-performance liquid chromatography. II: In vitro method for the evaluation of activated charcoal as a poison antidote.
    Kleeman WP; Bailey LC
    J Pharm Sci; 1988 Jun; 77(6):506-10. PubMed ID: 3171930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absorption of sodium pentobarbital by three types of activated charcoal.
    Curd-Sneed CD; McNatt LE; Stewart JJ
    Vet Hum Toxicol; 1986 Dec; 28(6):524-6. PubMed ID: 3788031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antidotal efficacy of activated charcoal in presence of jam, starch and milk.
    De Neve R
    Am J Hosp Pharm; 1976 Sep; 33(9):965-6. PubMed ID: 990044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adsorption of oral antidotes for acetaminophen poisoning (methionine and n-acetylcysteine) by activated charcoal.
    Klein-Schwartz W; Oderda GM
    Clin Toxicol; 1981 Mar; 18(3):283-90. PubMed ID: 7237961
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The binding of strychnine and strychnine analogs to synaptic membranes of rat brainstem and spinal cord.
    Mackerer CR; Kochman RL; Shen TF; Hershenson FM
    J Pharmacol Exp Ther; 1977 May; 201(2):326-31. PubMed ID: 16120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Theanine enhanced both the toxicity of strychnine and anticonvulsion of pentobarbital sodium.
    Yu XC; Wu BL; Gao JC; Yang W
    Drug Chem Toxicol; 2016; 39(2):217-23. PubMed ID: 26330182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversible adsorption of nicotinic acid onto charcoal in vitro.
    Roivas L; Neuvonen PJ
    J Pharm Sci; 1992 Sep; 81(9):917-9. PubMed ID: 1432640
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution.
    Hoffman RS; Chiang WK; Howland MA; Weisman RS; Goldfrank LR
    J Toxicol Clin Toxicol; 1991; 29(2):191-201. PubMed ID: 2051506
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accelerated clearance of intravenously administered theophylline and phenobarbital by oral doses of activated charcoal in rats. A possibility of the intestinal dialysis.
    Arimori K; Nakano M
    J Pharmacobiodyn; 1986 May; 9(5):437-41. PubMed ID: 3761133
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of activated charcoal on absorption of tolbutamide and valproate in man.
    Neuvonen PJ; Kannisto H; Hirvisalo EL
    Eur J Clin Pharmacol; 1983; 24(2):243-6. PubMed ID: 6404636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of delayed activated charcoal administration in simulated paracetamol (acetaminophen) overdose.
    Yeates PJ; Thomas SH
    Br J Clin Pharmacol; 2000 Jan; 49(1):11-4. PubMed ID: 10606832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of activated charcoal and sorbitol on sodium pentobarbital absorption in the rat.
    Curd-Sneed CD; Bordelon JG; Parks KS; Stewart JJ
    J Toxicol Clin Toxicol; 1987; 25(7):555-66. PubMed ID: 3446822
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Decreased phenobarbital absorption with charcoal administration for chronic renal failure.
    Tanaka C; Yagi H; Sakamoto M; Koyama Y; Ohmura T; Ohtani H; Sawada Y
    Ann Pharmacother; 2004 Jan; 38(1):73-6. PubMed ID: 14742799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In-vitro adsorption studies of isoniazid.
    Orisakwe OE; Akintonwa A
    Hum Exp Toxicol; 1991 Mar; 10(2):133-5. PubMed ID: 1675105
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of activated charcoal in a simulated poisoning with acetaminophen: a new loading dose for N-acetylcysteine?
    Chamberlain JM; Gorman RL; Oderda GM; Klein-Schwartz W; Klein BL
    Ann Emerg Med; 1993 Sep; 22(9):1398-402. PubMed ID: 8363113
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated charcoal administration in a pediatric emergency department.
    Osterhoudt KC; Alpern ER; Durbin D; Nadel F; Henretig FM
    Pediatr Emerg Care; 2004 Aug; 20(8):493-8. PubMed ID: 15295243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liquid phase adsorption behavior of inulin-type fructan onto activated charcoal.
    Li K; Liu S; Xing R; Yu H; Qin Y; Li P
    Carbohydr Polym; 2015 May; 122():237-42. PubMed ID: 25817664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The new black magic: activated charcoal and new therapeutic uses.
    Katona BG; Siegel EG; Cluxton RJ
    J Emerg Med; 1987; 5(1):9-18. PubMed ID: 3295011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.